DailyDoctor Archive Specialties Get app
Back to the 5 September 2026 edition

Regulatory · 03 of 05

European consensus on office-based laryngology

No ENT regulatory action today, but a new European Delphi consensus sets out 60 statements on office-based laryngology, including agreed indications and contraindications — useful where these procedures have outpaced agreement on when they are appropriate.

Today's regulatory sweep found no new drug approval or safety communication relevant to ENT. That is the expected pattern for this desk: what changes ENT practice is society standards, appropriateness criteria and procedural consensus, published as journal documents that drug-regulator feeds never see.

The substantive publication is a European practice consensus on office-based laryngology, developed by 25 laryngologists from the British Laryngological Association, the European Laryngological Society and the Union of European Phoniatricians through a modified Delphi process. Sixty statements were approved across two voting rounds, with consensus requiring 80% agreement and GRADE used for assessment. They cover preprocedural considerations, indications and contraindications, technical considerations, vocal fold augmentation, postprocedural care and success criteria, and environmental and economic outcomes.

Primary indications reached consensus for polyps, Reinke's oedema, varices, leukoplakia, biopsies, granulomas, recurrent respiratory papillomatosis and selected vocal fold augmentation. The value of the document is that office-based procedures have spread faster than agreement on when they are appropriate, and a patient having an awake procedure that should have been done under general anaesthesia is a specific and avoidable harm. Note the level of evidence is stated as not applicable — this is structured expert agreement, not trial data.

  • No ENT drug or device regulatory action in today's sweep
  • 60 consensus statements from 25 European laryngologists
  • Indications include polyps, Reinke's oedema, leukoplakia, papillomatosis, biopsy
  • Level of evidence stated as not applicable — expert consensus, not trial data

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

vestibularheadneckonclaryngologysleepairway

Tomorrow morning, before your first patient

One edition a day for ent & head and neck surgery, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app